-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Initiates Coverage On Repligen with Buy Rating, Announces Price Target of $160

Benzinga·04/17/2026 15:07:17
Listen to the news
Roth Capital analyst Natalya Davies initiates coverage on Repligen (NASDAQ:RGEN) with a Buy rating and announces Price Target of $160.